Concepedia

Romain Marignier

RM

Statistics

Publications

144

Citations

10K

H-Index

55

Active since

2005

Affiliations

Hospices Civils de Lyon(Current)

Hôpital Pierre Wertheimer

Inserm

Centre National de la Recherche Scientifique

Université Claude Bernard Lyon 1

Romain Marignier is an author at Hospices Civils de Lyon specializing in neurology, life sciences, and neuroimmunology.

ORCID

Publications per year

2005–2025

144

Publications

144

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial

Bruce Cree, Jeffrey L. Bennett, Ho Jin Kim et al. · The Lancet · 2019 · 717 citations

, , +4

Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults

Álvaro Cobo‐Calvo, Anne Ruiz, Élisabeth Maillart et al. · Neurology · 2018 · 532 citations

, , +17

Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease

Yael Hacohen, Yu Yi M. Wong, Christian Lechner et al. · JAMA Neurology · 2018 · 415 citations · Full text

, , +16

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study

Jens Kühle, Giulio Disanto, Ruth Dobson et al. · Multiple Sclerosis Journal · 2015 · 296 citations · Full text

, , +10

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica

Patrick Waters, Markus Reindl, Albert Saiz et al. · Journal of Neurology Neurosurgery & Psychiatry · 2016 · 296 citations · Full text

, , +16

1–5 of 144